These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5720347)

  • 1. [Comparison of distribution, narcotic activity and metabolic elimination of the optical antipodes of methylphenobarbital].
    Büch H; Buzello W; Neurohr O; Rummel W
    Biochem Pharmacol; 1968 Dec; 17(12):2391-8. PubMed ID: 5720347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distribution, metabolic elimination and narcotic efficacy of the optical antipodes of methylphenobarbital].
    Büch H; Rummel W; Buzello W; Neurohr O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):99-101. PubMed ID: 4239260
    [No Abstract]   [Full Text] [Related]  

  • 3. Stereospecificity of anesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates.
    Büch H; Knabe J; Buzello W; Rummel W
    J Pharmacol Exp Ther; 1970 Dec; 175(3):709-16. PubMed ID: 5496138
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of experimental local inflammation on the action of barbiturates in rat.
    Prabhu VG; Rise NL; Oester YT
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):343-50. PubMed ID: 5015939
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of barbiturates on rats of different ages].
    Kuhlmann K; Oduah M; Coper H
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 265(4):310-20. PubMed ID: 4244608
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies.
    van der Graaff M; Vermeulen NP; Langendijk PN; Breimer DD
    J Pharmacol Exp Ther; 1983 Jun; 225(3):747-51. PubMed ID: 6134816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies of enzyme-inducing ability of phenobarbital, methylphenobarbital, glutethimide and their N-substituted morphoalkylic derivatives].
    Staneva-Stoĭcheva D; Popov P; Kitova E; Mileva M
    Eksp Med Morfol; 1977; 16(1):33-9. PubMed ID: 880910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance experiments with barbitone-dependent rats.
    Turnbull MJ; Stevenson IH
    J Pharm Pharmacol; 1968 Nov; 20(11):884-5. PubMed ID: 4387501
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of pyriditol on drug metabolism].
    Avakumov VM; Kovler MA
    Farmakol Toksikol; 1980; 43(4):417-21. PubMed ID: 7192219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hypersensitivity of brain by hydralazine treatment in rats.
    Hara S; Satoh T; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):251-7. PubMed ID: 7221180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of barbiturate hypnosis by probenecid: differential effect in tolerant animals.
    Lyness WH; Mycek MJ
    Neuropharmacology; 1981 Mar; 20(3):217-26. PubMed ID: 7266783
    [No Abstract]   [Full Text] [Related]  

  • 12. Reticuloendothelial stimulation and drug metabolism.
    Barnes DW; Wooles WR
    J Reticuloendothel Soc; 1970 Jun; 7(6):684-94. PubMed ID: 4317319
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of acetazolamide on barbiturate-induced sleeping time in mice. III. Pharmacokinetics of serum elimination and brain distribution.
    Sato J; Ueda K; Saito A; Tada H; Owada E; Ito K; Murata T
    J Pharmacobiodyn; 1983 Jun; 6(6):381-90. PubMed ID: 6631659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetic differences in the microsomal metabolism of the isomers of hexobarbital.
    McCarthy JS; Stitzel RE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):772-8. PubMed ID: 5111462
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-tolerance to centrally injected barbiturates.
    Lyness WH; Brezenoff HE; Mycek MJ
    Eur J Pharmacol; 1979 Mar; 54(4):319-30. PubMed ID: 436931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of caffeine on barbiturate sleeping time and brain level.
    Aeschbacher HU; Atkinson J; Domahidy B
    J Pharmacol Exp Ther; 1975 Mar; 192(3):635-41. PubMed ID: 1120961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of restraint on the activity, penetration and metabolism of hexobarbital and barbital in white rats].
    Buchel L; Prioux-Guyonneau M; Liblau L; Murawsky M
    Therapie; 1972; 27(4):609-25. PubMed ID: 4673389
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolic fate of hexobarbital in the rat.
    Holcomb RR; Gerber N; Bush MT
    J Pharmacol Exp Ther; 1974 Jan; 188(1):15-26. PubMed ID: 4809266
    [No Abstract]   [Full Text] [Related]  

  • 20. [Narcotic effectiveness and tissue distribution of the optical antipodes of the pentobarbitals in the rat].
    Büch H; Grund W; Buzello W; Rummel W
    Biochem Pharmacol; 1969 May; 18(5):1005-9. PubMed ID: 5789769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.